Net Loss Per Share (Tables)

9 Months Ended

Sep. 30, 2020

Earnings Per Share [Abstract]

Schedule of Outstanding Shares of Common Stock Equivalents Excluded from Calculation of Diluted Net Loss Per Share

The following shares of common stock equivalents were excluded from the calculation of diluted net loss per share for the periods presented because including them would have been antidilutive:

	September 30, 2020		September 30, 2019
Series A warrants for common stock		7,802,241		—
Series B warrants for common stock		2,574,727		—
Options to purchase common stock		4,246,167		328,656
Warrants for common stock		727,122		1,839
Total potential dilutive shares		15,350,257		330,495